Description

Radiographer role development has touched boundaries across the multidisciplinary team and more recently branched into the field of gynecology. Radiographers are now able to perform tasks that were traditionally performed by radiologists and gynecologists to implement a radiographer-led Hysterosalpingogram (HSG) service. The aims of the study were to (i) implement a radiographer-led HSG service with a view to decreasing waiting times. (ii) To determine ladies perceptions and satisfaction levels. The female reproductive organs consist of the cervix, uterus, fallopian tubes, and paired ovaries. During the initial 6 weeks of gestation, both male and female fetuses possess paired Mullerian (paramesonephric) and Wolffian (mesonephric) ducts.

In male fetuses, the presence of Müllerian-inhibiting factor, associated with the presence of a Y chromosome, results in the regression of the Müllerian ducts. In female fetuses, the absence of Müllerian-inhibiting factor leads to concomitant regression. Assure hysteroscopy sterilization is an effective permanent contraception option for women, with a 99.83% effectiveness rate. To date, more than 600,000 Assure procedures have been performed worldwide. This case report describes bilateral Assure insert placement, after which the left insert was subsequently expelled after hysterosalpingogram (HSG)–confirmed correct bilateral insert placement and bilateral tubal occlusion. Although insert expulsion has been reported before a 3-month post-procedure HSG, this is the first published report of expulsion after a confirmatory 3-month post-procedure HSG. Because there now exists documentation of Assure insert expulsion after a 3-month confirmatory HSG, physicians and patients should be informed of this rare occurrence. Further investigation into the causes of such an event is warranted. Many women experience pain during hysterosalpingogram (HSG), which is a test used to evaluate the uterine cavity and fallopian tube. We conducted a prospective, randomized, double-blinded, placebo-controlled study to assess whether the use of benzocaine spray during HSG is associated with reduced pain as compared with placebo. Thirty women presenting for HSG were enrolled and randomized to either benzocaine or saline spray. Treatment groups were similar in age, race, previous pregnancies, pre-procedure oral analgesic use and history of dysmenorrhea (painful periods) and/or chronic pelvic pain. There was no difference in pain scores or resolution of pain between the two groups. Satisfaction scores did not differ by treatment group and did not correlate with the pain score during the procedure. We conclude that the use of benzocaine spray does not significantly improve pain relief during HSG nor does it hasten resolution of pain post HSG. Of interest, patient satisfaction was not correlated with pain.

Kindly submit your manuscript through https://www.imedpub.com/submissions/reproductive-endocrinology-infertility.html

With Regards
Sellina

Journal Coordinator
Journal of Reproductive Endocrinology & Infertility